Defence Therapeutics Inc (DTC.CX)
0.51
+0.01
(+2.00%)
CAD |
CNSX |
Aug 25, 16:00
Defence Therapeutics Total Assets (Quarterly) : 9.446M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 9.446M |
| December 31, 2025 | 1.369M |
| September 30, 2025 | 2.768M |
| June 30, 2025 | 1.652M |
| March 31, 2025 | 2.364M |
| December 31, 2024 | 0.403M |
| September 30, 2024 | 0.4247M |
| June 30, 2024 | 0.4777M |
| March 31, 2024 | 0.9683M |
| December 31, 2023 | 0.6688M |
| September 30, 2023 | 1.588M |
| June 30, 2023 | 3.533M |
| Date | Value |
|---|---|
| March 31, 2023 | 3.149M |
| December 31, 2022 | 0.4465M |
| September 30, 2022 | 0.3007M |
| June 30, 2022 | 0.7197M |
| March 31, 2022 | 1.826M |
| December 31, 2021 | 3.203M |
| September 30, 2021 | 4.869M |
| June 30, 2021 | 5.609M |
| March 31, 2021 | 6.755M |
| December 31, 2020 | 7.168M |
| September 30, 2020 | |
| June 30, 2020 | 1.912M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Spectral Medical, Inc. | 3.19M |
| Resverlogix Corp. | 11.71M |
| Theratechnologies, Inc. | 70.49M |
| COSCIENS Biopharma, Inc. | 26.74M |
| Restart Life Sciences Corp. | 2.284M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.031M |
| Shareholders Equity (Quarterly) | 5.415M |
| Debt to Equity Ratio | 0.2889 |
| Current Ratio | 3.367 |
| Net Debt Paydown Yield | -0.13% |